Insider Stock Trading History of Callicutt Jack W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Callicutt Jack W since year 2005. The trader's CIK number is 1266773. At the time of this reporting, Callicutt Jack W is the Chief Financial Officer of Galectin Therapeutics Inc . (stock ticker symbol GALT). See this page for all insider trading activities at Galectin Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Callicutt Jack W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-19 GALT Galectin Therapeutics Inc Option Ex 128,733 3.93 505,920
2018-06-20 GALT Galectin Therapeutics Inc Option Ex 97,267 4.41 428,947
2018-06-19 GALT Galectin Therapeutics Inc Sale 128,733 9.01 1,160,013
2018-06-20 GALT Galectin Therapeutics Inc Sale 97,267 8.08 786,014
2018-06-12 GALT Galectin Therapeutics Inc Sale 9,294 7.01 65,169
2018-06-12 GALT Galectin Therapeutics Inc Option Ex 9,294 1.37 12,732
2018-06-08 GALT Galectin Therapeutics Inc Option Ex 100,000 .87 87,000
2018-06-08 GALT Galectin Therapeutics Inc Sale 100,000 5.75 575,000
2018-06-11 GALT Galectin Therapeutics Inc Option Ex 20,000 1.37 27,400
2018-06-11 GALT Galectin Therapeutics Inc Sale 20,000 6.38 127,500
2018-05-31 GALT Galectin Therapeutics Inc Option Ex 46,651 .87 40,586
2018-05-31 GALT Galectin Therapeutics Inc Sale 46,651 5.00 233,255
2018-04-04 GALT Galectin Therapeutics Inc Option Ex 3,349 .87 2,913
2018-04-04 GALT Galectin Therapeutics Inc Sale 3,349 5.00 16,745
2014-08-14 GALT Galectin Therapeutics Inc Buy 1,000 4.54 4,545
2013-11-19 GALT Galectin Therapeutics Inc Buy 260 6.25 1,625

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Callicutt Jack W (Chief Financial Officer of Galectin Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.